Clinical Trials Logo

Dizziness clinical trials

View clinical trials related to Dizziness.

Filter by:

NCT ID: NCT04196933 Enrolling by invitation - Migraine Clinical Trials

Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma

Start date: September 5, 2019
Phase: N/A
Study type: Interventional

Multiple sensory cues are typically generated by discrete events, and while they do not reach the cerebrum simultaneously, the brain can bind them temporally if they are interpreted as corresponding to a single event. The temporal binding of vestibular and non-vestibular sensory cues is poorly understood and has not been studied in detail, despite the fact that the vestibular system operates in an inherently multimodal environment. In this study, the researchers are investigating the physiology and pathophysiology of vestibular temporal binding by studying normal subjects, patients with peripheral and central vestibular dysfunction, and patients with vestibular and cochlear signals provided by prosthetic implants in the inner ear.

NCT ID: NCT04183842 Completed - Anxiety Clinical Trials

Evaluation of a Fixed Combination of Herbal Extracts to Prevent Symptoms Alcohol-induced Hangovers

LACIME
Start date: July 4, 2019
Phase: N/A
Study type: Interventional

The primary objective of the study is to test whether the tested Product LACIME Anti-hangover is effective in preventing the signs and symptoms of alcohol-induced hangover (such as headache, impaired memory, depression, anxiety, weakness, trouble sleeping and concentrating, nausea, dizziness, sleepiness, thirsty, dry mouth, sweating, sensitivity to light and sounds, vision problems) in healthy subjects.

NCT ID: NCT04141891 Completed - Stroke Clinical Trials

Advancing Understanding of Transportation Options

AUTO
Start date: December 12, 2019
Phase: N/A
Study type: Interventional

This Stage II randomized, controlled, longitudinal trial seeks to assess the acceptability, feasibility, and effects of a driving decision aid use among geriatric patients and providers. This multi-site trial will (1) test the driving decision aid (DDA) in improving decision making and quality (knowledge, decision conflict, values concordance and behavior intent); and (2) determine its effects on specific subpopulations of older drivers (stratified for cognitive function, decisional capacity, and attitudinally readiness for a mobility transition). The overarching hypotheses are that the DDA will help older adults make high-quality decisions, which will mitigate the negative psychosocial impacts of driving reduction, and that optimal DDA use will target certain populations and settings.

NCT ID: NCT04117620 Completed - Dizziness Clinical Trials

Validity of the French Version of the Child's Vestibular Disorder Symptoms Questionnaire

QEV-FR
Start date: April 28, 2020
Phase:
Study type: Observational

There is currently no score in French for evaluating disorders of the child's balance. Only one questionnaire was validated in the child in English in 2016, the " Pediatric Vestibular Symptom Questionnaire ". The objective of the research is to validate the French translation of this questionnaire.

NCT ID: NCT04070664 Completed - Oxidative Stress Clinical Trials

Thiol/Disulphide Homeostasis and Albumin in Vertigo

Start date: July 1, 2018
Phase:
Study type: Observational

Vertigo is a common complaint in the Emergency Department (ED). The differential diagnosis of central and peripheral vertigo is a difficult issue that directly affects mortality. Magnetic resonance imaging (MRI) is the preferred diagnostic tool, but may not be suitable in all patients due to logistic and economic conditions. In this study, the investigators evaluated the role of thiol/disulfide homeostasis (TDH) parameters and ischemia modified albumin (IMA) levels to assist in the value of being used instead of MRI.

NCT ID: NCT04026516 Suspended - Clinical trials for Benign Paroxysmal Positional Vertigo

CAVA: Dizziness Trial

CAVA
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Clinical investigation of a medical device (CAVA) for recording eye movements. Patients suffering from diagnosed dizziness conditions will wear the device for 23 hours a day, for 30 days. The device will capture normal eye movement data as well as data corresponding to any dizzy events experienced. At the end of the trial, the data will be downloaded and a scientist will perform a blinded analysis of the data. Specifically, they will attempt to identify the dates on which dizziness was reported.

NCT ID: NCT03994809 Completed - Pain Clinical Trials

International Study of Biofield Therapy

Start date: January 1, 2008
Phase:
Study type: Observational

Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.

NCT ID: NCT03974464 Completed - Vertigo, Peripheral Clinical Trials

Copeptin and the S-100b Protein in Stroke

Start date: May 1, 2016
Phase:
Study type: Observational

This study evaluated the value of using copetin and protein S 100 b to eliminate the diagnosis of stroke in patients presenting with vertigo in emergency departments. All patients benefited from the S 100b protein assay, copeptin and brain MRI.

NCT ID: NCT03973658 Not yet recruiting - Hearing Loss Clinical Trials

Dizziness Among First Time Users of Hearing Aids

Start date: September 1, 2019
Phase:
Study type: Observational

The score on the Dizziness Handicap Inventory (short version) before and after hearing aid fitting and usage will be compared

NCT ID: NCT03930485 Completed - Dizziness Clinical Trials

Risk Factors for Persistent Postural-Perceptual Dizziness Development

RIPPPDD
Start date: April 9, 2019
Phase:
Study type: Observational

The primary aim of this study is to determine whether the prevalence of neuroticism, anxiety and body vigilance is higher in patients diagnosed with PPPD compared to those who suffered a vestibular insult but did not develop PPPD and healthy controls. An increased prevalence of one or more of these factors may identify them as risk factors in the development of PPPD. The secondary aim is to understand how PPPD affects quality of life.